Search Results 631-640 of 16245 for pharmacogenetics
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...
Also, to assess insulin sensitivity using the QUICKI measure and will assess changes after just 3 months in both ISS and QUICKI. Additionally, to assess whether ...
Dr. Maia's Functional Epigenomics Lab at Mayo Clinic investigates epigenomic profiling, chromatin, biomarker discovery and tumor-specific enhancers.
The Mayo Clinic Kern Center for the Science of Health Care Delivery works with The Dartmouth Institute to accelerate use of evidence-based innovation in ...
POC-20489938. Final days of 5X Challenge! 5X My Gift! The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.
Mayo Clinic researchers find ways to reduce toxicity and improve response rates in CAR-T cell therapy: Mayo Clinic Forefront cancer magazine.
The purpose of this study is to test whether metagenomic shotgun sequencing can identify pathogens causing cardiovascular infections such as infective ...
The purpose of this study is to see how changes in the amount of oxygen breathed can affect how the body responds to changes in blood sugar. Participation ...
With obesity comes an increasing risk of cardiovascular disease, including stroke, congestive heart failure and myocardial infarction.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.